首页> 外国专利> MOLECULAR BEACONS FOR DETECTING MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS AND USES THEREOF

MOLECULAR BEACONS FOR DETECTING MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS AND USES THEREOF

机译:用于检测中东呼吸综合征冠状病毒的分子信标及其用途

摘要

The present invention relates to a molecular beacon for the detection of Middle East respiratory syndrome coronavirus (MERS-CoV). More specifically, the present invention relates to a molecular beacon for detecting the nsp3 region of the MERS-CoV and the M base sequence region which is a structural protein region, a kit for the diagnosis of a MERS-CoV infection using the same, and a method for detecting MERS-CoV. The molecular beacon of the present invention has a target affinity higher than the affinity of an antibody and is much smaller in size than an antibody and an aptamer so that the beacon can react with a target molecule with a high binding force. In addition, the molecular beacon is not sensitive to temperature change, has no denaturation, and has the advantage of enabling detection with only a small amount of target nucleic acid molecules within a short time. Furthermore, since detection is possible by a simple method using fluorescence or UV spectrum, a kit for detecting MERS-CoV using the molecular beacon of the present invention can be widely used for the diagnosis of a MERS-CoV infection.
机译:本发明涉及一种用于检测中东呼吸综合征冠状病毒(MERS-CoV)的分子信标。更具体地,本发明涉及用于检测MERS-CoV的nsp3区域和作为结构蛋白区域的M碱基序列区域的分子信标,使用其来诊断MERS-CoV感染的试剂盒,以及一种用于检测MERS-CoV的方法。本发明的分子信标具有比抗体的亲和力高的靶标亲和力,并且其大小比抗体和适体小得多,使得该信标可以高结合力与靶标分子反应。另外,该分子信标对温度变化不敏感,不具有变性,并且具有能够在短时间内仅用少量靶核酸分子进行检测的优点。此外,由于可以通过使用荧光或UV光谱的简单方法进行检测,因此使用本发明的分子信标检测MERS-CoV的试剂盒可以广泛用于MERS-CoV感染的诊断。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号